Vaccination for 45-plus stopped for three days in Gujarat
SECTIONS
Last Updated: May 14, 2021, 01:24 PM IST
Share
Synopsis
The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine from 6 to 8 weeks now to 12 to 16 weeks following a recommendation from a government panel.
Agencies
Inoculation of people in the age group 45 and above in Gujarat was halted for three days from Friday following a revision in the COVID-19 vaccination schedule after the Centre s decision to increase the gap between two doses of Covishield, the state government said.
However, during these three days, vaccination will continue for people in the age group of 18 to 44 years who have already registered themselves and received SMSes, said a state government release.
Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
Track the industry of your choice with a daily newsletter specific to that industry.
Stay on top of your investments. Track stock prices in your portfolio.
NOTE :
The monthly duration product is an auto renewal based product. Once subscribed, subject to your card issuer s permission we will charge your card/ payment instrument each month automatically and renew your subscription.
In the Annual duration product we offer both an auto renewal based product and a non auto renewal based product.
Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive Sneha Mordani
Chairman of India s Technical Advisory Group on Covid-19 vaccination, Dr NK Arora, has defended the Centre s decision to increase the gap between both doses of Covishield to 12-16 weeks from the earlier norm of 6-8 weeks. The Health Ministry accepted the recommendation on Thursday.
It was the National Technical Advisory Group on immunisation headed by Dr Arora that had recommended extending the gap between two doses of the Covid-19 vaccine. Covishield, developed by the University of Oxford and AstraZeneca, is being produced by Pune-based Serum Institute of India (SII).
Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive Sneha Mordani
Chairman of India s Technical Advisory Group on Covid-19 vaccination, Dr NK Arora, has defended the Centre s decision to increase the gap between both doses of Covishield to 12-16 weeks from the earlier norm of 6-8 weeks. The Health Ministry accepted the recommendation on Thursday.
It was the National Technical Advisory Group on immunisation headed by Dr Arora that had recommended extending the gap between two doses of the Covid-19 vaccine. Covishield, developed by the University of Oxford and AstraZeneca, is being produced by Pune-based Serum Institute of India (SII).
Gap between Covishield doses extended based on real-life data, not to spare jabs: Dr NK Arora | Exclusive
Dr NK Arora, Chairman of India s Technical Advisory Group on Covid-19 vaccination, addressed key concerns about the recommendation to extend the gap between two doses of Covishield and whether the Covid-19 vaccine is safe for lactating women.
advertisement
UPDATED: May 15, 2021 00:38 IST
A medic prepares to administer a dose of Covid-19 vaccine Covishield at a vaccination centre in Delhi on May 3, 2021 (Photo Credits: PTI)
HIGHLIGHTS
Lactating women are eligible for getting the Covid-19 vaccines: Dr NK Arora
Setting up platform to monitor breakthrough infections, will review decision after 3-4 months: Dr NK Arora